RAPP Buy Disclosure
Healy James · SEC Form 4 · Filed Oct 30, 2026
Buy
Calculated transaction value
$79.21K
Healy James Director
RAPP
Rapport Therapeutics
RAPP
Transaction date
Oct 28, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 2 days later
RAPP daily price context
Close on/before transaction
$22.5
Oct 28, 2026
First close after public filing
$25.13
Nov 2, 2026
Return after filing · so far
-2.75%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,772 shares @ $21
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001104659-26-120789
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$20.36M
Buys / sales
4 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP | Buy | Oct 28, 2026 | $145.59K |
| Rapport Therapeutics, Inc. RAPP | Buy | Oct 28, 2026 | $134.29K |
| Rapport Therapeutics, Inc. RAPP | Buy | Oct 28, 2026 | $20M |
| Rapport Therapeutics, Inc. RAPP Current | Buy | Oct 28, 2026 | $79.21K |